Developer docs
API playgroundTry for free, no card

Search company profiles

The Spanish Association of Biotech companies (ASEBIO)

Full company profile

uuid000pp3e

Namestring
The Spanish Association of Biotech companies (ASEBIO)
Legal namestring
Asociación Española de Bioempresas (AseBio)
Websiteurl
asebio.com
Company typeenum
Private
Founded yearint
1999
Descriptiontext

ASEBIO (Asociación Española de Bioempresas) is the Spanish Association of Biotech Companies, a non-profit trade association founded in 1999 and headquartered in Madrid (Diego de León 49) that represents 350 member companies and entities in Spain's biotechnology ecosystem. Its membership spans startups (15% are under three years old), SMEs, and large pharmaceutical and biotech firms, with 65.5% of members active in health and others in agrobiotechnology, industrial biotechnology, and the bioeconomy.

ASEBIO's product portfolio centers on ecosystem-orchestration services rather than software products. Flagship offerings include BIOSPAIN, billed as the largest country-based biotech event in Europe; the AseBio Investor Day; the annual Informe AseBio sector report (2025 edition: 'Biotech Act: una oportunidad para la biotecnología española'); the Plataforma Biotech (PBio) digital ecosystem for partnering, capability publishing, and bilateral meetings; the Bolsa de Empleo job board; the Observatorio Ayudas I+D funding observatory; and talent and diversity programs (Joven Talento Biotech, #MujerBiotech). Since 2008 ASEBIO has managed the ICEX Internationalization Plan for biotech companies, giving it privileged distribution into internationalization, trade events, and market-access support.

The business model is membership-fee revenue supplemented by institutional partnerships and project funding from Spanish and European public bodies (ICEX, CDTI, Ministerio de Industria, Ministerio de Ciencia e Innovación, Ministerio de Sanidad, Agencia Estatal de Investigación, and the PERTE Salud de Vanguardia Alliance). Pricing is not publicly disclosed. Go-to-market is primarily through direct member engagement, the asebio.com and plataformabiotech.com digital properties, events, and public-policy advocacy. Leadership comprises Director General Ion Arocena, President Rocío Arroyo (CEO of Amadix), and Vice President Javier Terriente. The association operates in Spanish (primary) and English, and serves as the central interlocutor between Spain's biotech sector and national and European policy and funding institutions.

Short descriptiontext

The Spanish Association of Biotech companies (ASEBIO) is a non-profit trade association founded in 1999 that represents 350 biotech companies and entities in Spain, providing networking, policy advocacy, talent programs, the BIOSPAIN event, and the Plataforma Biotech digital ecosystem.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMadrid, Spain
HQ citystring
Madrid
HQ countrystring
Spain
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biotech industry association, biotechnology networking services, biotech partnering platform, biotech internationalization services, biotech sector advocacy
Industry1 code
1Antisense Oligonucleotides (ASO) Therapeutics (splice modulation/knockdown)
CodeHLAAADACPrimaryYes
NAICS code2 codes
  • Technical and Trade Schools6115
  • Other Technical and Trade Schools611519
SIC code1 code
  • Services-Educational Services8200
Product category
Biotechnology Trade Association Services
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

ASEBIO is a Spanish non-profit trade association that represents and convenes the national biotechnology sector. It sells membership to biotech companies and delivers a portfolio of services: the annual Informe AseBio sector report, the Plataforma Biotech digital partnering platform, the BIOSPAIN conference and AseBio Investor Day events, a job board, an R&D funding observatory, and talent development programs. Its core activity is intermediating between Spanish biotech companies, research institutions, government bodies, and international markets.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 350 member companies and entities in the Spanish biotech ecosystem
+4 more records
Product overview1 text field

AseBio is a trade association representing Spanish biotechnology companies. Rather than a unified software product, it offers a portfolio of services including publications (Informe AseBio annual report), the Plataforma Biotech digital platform for partnering and talent, flagship events (BIOSPAIN conference, Investor Day), a job board, an R&D funding observatory, and talent development programs (Joven Talento Biotech, #MujerBiotech).

Product and service3 records
1Informe AseBio
CategoryPublication
Description

Annual comprehensive report on the Spanish biotechnology sector, providing data on investment, employment, pipelines, and sector trends. Targeted at biotech companies, investors, policymakers, and sector stakeholders.

2Plataforma Biotech (PBio)
CategoryDigital Platform
Description

Digital platform managed by ASEBIO for biotech ecosystem collaboration, featuring a partnering tool, talent programs, and networking capabilities. Funded by the Agencia Estatal de Investigación. Connects biotech companies, research centers, universities, and investors.

3BIOSPAIN
Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership11 partners
Strategic tierCoreTypeOthersAnnounced on2026-01-01
Description

CDTI publishes funding calls including INNTERCONECTA STEP 2025 where 23 biotech projects received 14.5 million euros in subsidies, with 7 ASEBIO members involved. ASEBIO monitors and reports on CDTI funding opportunities for its members.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2008-01-01
Description

Since 2008, ASEBIO has managed the 'Plan de Internacionalización de ICEX para las empresas biotecnológicas', supporting Spanish biotech companies in international expansion. ICEX provides funding and programmatic support for international missions, trade events, and market access activities.

Strategic tierCoreTypeOthers
Description

The Ministry published the PROFARMA 2025-2026 resolution where 15 ASEBIO members received Excellent to Acceptable classifications. ASEBIO advocates for the sector with this ministry and participates in the PERTE Salud de Vanguardia Alliance.

Strategic tierCoreTypeOthers
Description

The Ministry leads national science and innovation policy. ASEBIO participates in the PERTE Salud de Vanguardia Alliance and collaborates on initiatives to convert excellent science into technology and innovation made in Spain.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

ASEBIO and SEBiot collaborate on the Joven Talento Biotech program to support young researchers and students. Entities must be ASEBIO members, Plataforma Biotech members, or associated with SEBiot to participate in the program.

6Plataforma Biotech (PBio)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

The Plataforma Biotech (PBio) is managed by ASEBIO and is a digital ecosystem that connects biotech actors, publishes capabilities and products, facilitates bilateral meetings, and promotes collaboration. Funded by the Agencia Estatal de Investigación.

asebio.com
Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

ASEBIO participates in the PERTE Salud de Vanguardia Alliance bringing together public administrations, regional governments, scientific societies, business associations, and patient groups. This strategic initiative represents a 1,469 million euro investment (2021-2023) expected to generate over 4,300 million euros in GDP and 12,700 new jobs.

Strategic tierCoreTypeOthers
Description

ASEBIO collaborates with the Ministry of Health on PERTE Salud de Vanguardia initiatives and healthcare innovation policy. Ministers Diana Morant and Carolina Darias led the alliance formation in April 2022.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Collaboration within the XV Conferencia Anual de las Plataformas Tecnológicas de Investigación Biomédica, organized alongside Farmaindustria, Fenin, Nanomed Spain and other platforms with over 700 registered attendees.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Co-organizer of the XV Conferencia Anual de las Plataformas Tecnológicas de Investigación Biomédica along with ASEBIO, Farmaindustria, and other sector platforms.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration on the 'Un día con una #MujerBiotech' program and other initiatives connecting female students with biotech professionals. This platform represents a network of biotech companies for partnering and market development.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

The largest US biotech industry association, representing 1,000+ members and organizing the BIO International Convention. ASEBIO is the Spanish national analogue at smaller scale, with comparable functions (policy advocacy, partnering events, member services) but concentrated in Spain rather than globally.

TypeBroad incumbent
Description

The European biotechnology industry federation based in Brussels, representing national associations and corporate members across Europe. ASEBIO participates in EuropaBio consultations on EU policy (Biotech Act) and serves a comparable ecosystem-coordinator function at national level.

TypeDirect peer
Description

French biotech trade association representing healthtech and biotech startups/SMEs in France. ASEBIO and France Biotech share a near-identical role: national ecosystem advocacy, policy lobbying, partnering events and startup support in adjacent European biotech markets.

4BIA (UK BioIndustry Association)
TypeDirect peer
Description

The UK's national trade association for the life sciences and biotech industry. BIA performs the same core functions as ASEBIO (policy advocacy, networking, conferences, partnering) but for a larger and more mature UK ecosystem.

TypeDirect peer
Description

Germany's biotechnology industry association, representing SMEs and large biotechs. Operates as the German counterpart to ASEBIO with analogous services (annual reports, partnering events, policy work) in a larger national market.

TypeDirect peer
Description

National biotech industry association for Switzerland, organizing Swiss Biotech Day and representing Swiss biotech at EU/global level. Directly comparable to ASEBIO in scope and member-services model, but serving the more established Swiss ecosystem.

TypeDirect peer
Description

Australia's national biotech industry association with similar functions: policy advocacy, internationalization support, member events and sector reports. Comparable to ASEBIO as a national trade body for a mid-sized biotech ecosystem.

TypeDirect peer
Description

Canada's national biotechnology industry association. Performs equivalent trade-association functions (BIO convention participation, policy advocacy, member services) for the Canadian biotech ecosystem.

TypeOthers
Description

Spanish pharmaceutical industry association and ASEBIO's listed partner (XV Conferencia Anual de Plataformas Tecnológicas). Adjacent rather than competitive — Farmaindustria represents large pharma while ASEBIO represents biotech — but they co-organize platforms and share policy space in Spain.

TypeOthers
Description

Spanish federation of healthcare technology companies (medical devices, diagnostics, digital health). Co-organizer with ASEBIO of the XV Conferencia Anual de Plataformas Tecnológicas; an adjacent health-innovation trade body with overlapping member ecosystems in Spain.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers19 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

The Spanish Association of Biotech companies (ASEBIO)

Biotechnology Trade Association Servicesasebio.com

The Spanish Association of Biotech companies (ASEBIO) is a non-profit trade association founded in 1999 that represents 350 biotech companies and entities in Spain, providing networking, policy advocacy, talent programs, the BIOSPAIN event, and the Plataforma Biotech digital ecosystem.

What The Spanish Association of Biotech companies (ASEBIO) does

ASEBIO (Asociación Española de Bioempresas) is the Spanish Association of Biotech Companies, a non-profit trade association founded in 1999 and headquartered in Madrid (Diego de León 49) that represents 350 member companies and entities in Spain's biotechnology ecosystem. Its membership spans startups (15% are under three years old), SMEs, and large pharmaceutical and biotech firms, with 65.5% of members active in health and others in agrobiotechnology, industrial biotechnology, and the bioeconomy.

ASEBIO's product portfolio centers on ecosystem-orchestration services rather than software products. Flagship offerings include BIOSPAIN, billed as the largest country-based biotech event in Europe; the AseBio Investor Day; the annual Informe AseBio sector report (2025 edition: 'Biotech Act: una oportunidad para la biotecnología española'); the Plataforma Biotech (PBio) digital ecosystem for partnering, capability publishing, and bilateral meetings; the Bolsa de Empleo job board; the Observatorio Ayudas I+D funding observatory; and talent and diversity programs (Joven Talento Biotech, #MujerBiotech). Since 2008 ASEBIO has managed the ICEX Internationalization Plan for biotech companies, giving it privileged distribution into internationalization, trade events, and market-access support.

The business model is membership-fee revenue supplemented by institutional partnerships and project funding from Spanish and European public bodies (ICEX, CDTI, Ministerio de Industria, Ministerio de Ciencia e Innovación, Ministerio de Sanidad, Agencia Estatal de Investigación, and the PERTE Salud de Vanguardia Alliance). Pricing is not publicly disclosed. Go-to-market is primarily through direct member engagement, the asebio.com and plataformabiotech.com digital properties, events, and public-policy advocacy. Leadership comprises Director General Ion Arocena, President Rocío Arroyo (CEO of Amadix), and Vice President Javier Terriente. The association operates in Spanish (primary) and English, and serves as the central interlocutor between Spain's biotech sector and national and European policy and funding institutions.

The Spanish Association of Biotech companies (ASEBIO) firmographics

Firmographics
Name
The Spanish Association of Biotech companies (ASEBIO)
Legal name
Asociación Española de Bioempresas (AseBio)
Website
https://asebio.com
Company type
Private
Founded year
1999
Operating status
Operating
Headcount range
11–50 employees
Short description
The Spanish Association of Biotech companies (ASEBIO) is a non-profit trade association founded in 1999 that represents 350 biotech companies and entities in Spain, providing networking, policy advocacy, talent programs, the BIOSPAIN event, and the Plataforma Biotech digital ecosystem.
Ownership category
akta.pro rank

The Spanish Association of Biotech companies (ASEBIO) industry classification

Industry
Product category
Biotechnology Trade Association Services
NAICS
Technical and Trade Schools (6115), Other Technical and Trade Schools (611519)
SIC
Services-Educational Services (8200)
akta.pro primary industry
Antisense Oligonucleotides (ASO) Therapeutics (splice modulation/knockdown) (HLAAADAC)

Keywords

  • Biotech industry association
  • Biotechnology networking services
  • Biotech partnering platform
  • Biotech internationalization services
  • Biotech sector advocacy

Where The Spanish Association of Biotech companies (ASEBIO) is headquartered

Location

Headquarters

HQ city
Madrid
HQ country
Spain
HQ region
Europe

Offices1 record

Markets served

The Spanish Association of Biotech companies (ASEBIO) business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Distribution channels4 records

Marketing channels8 records

The Spanish Association of Biotech companies (ASEBIO) product offering

Product offering

Core offering

ASEBIO is a Spanish non-profit trade association that represents and convenes the national biotechnology sector. It sells membership to biotech companies and delivers a portfolio of services: the annual Informe AseBio sector report, the Plataforma Biotech digital partnering platform, the BIOSPAIN conference and AseBio Investor Day events, a job board, an R&D funding observatory, and talent development programs. Its core activity is intermediating between Spanish biotech companies, research institutions, government bodies, and international markets.

Product overview

AseBio is a trade association representing Spanish biotechnology companies. Rather than a unified software product, it offers a portfolio of services including publications (Informe AseBio annual report), the Plataforma Biotech digital platform for partnering and talent, flagship events (BIOSPAIN conference, Investor Day), a job board, an R&D funding observatory, and talent development programs (Joven Talento Biotech, #MujerBiotech).

Differentiator

Problem solved

Functional benefit

Products and services

  • Informe AseBio Annual comprehensive report on the Spanish biotechnology sector, providing data on investment, employment, pipelines, and sector trends. Targeted at biotech companies, investors, policymakers, and sector stakeholders.
  • Plataforma Biotech (PBio) Digital platform managed by ASEBIO for biotech ecosystem collaboration, featuring a partnering tool, talent programs, and networking capabilities. Funded by the Agencia Estatal de Investigación. Connects biotech companies, research centers, universities, and investors.
  • BIOSPAIN

Quantifiable outcome

  • 350 member companies and entities in the Spanish biotech ecosystem
  • +4 more outcomes

Companies that use The Spanish Association of Biotech companies (ASEBIO)

Customer profile

Named customers19 records

Segments3 records

Ideal customer profiles2 records

The Spanish Association of Biotech companies (ASEBIO) technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

The Spanish Association of Biotech companies (ASEBIO) partnerships and signals

Strategic signal

Partnerships

Eleven partnerships are on record, tiered core, flagship and minor.

  • CDTI (Centro para el Desarrollo Tecnológico Industrial)coreOthers · 1 January 2026CDTI publishes funding calls including INNTERCONECTA STEP 2025 where 23 biotech projects received 14.5 million euros in subsidies, with 7 ASEBIO members involved. ASEBIO monitors and reports on CDTI funding opportunities for its members.
  • ICEX (Instituto de Comercio Exterior)flagshipStrategic or Co-development Partner · 1 January 2008Since 2008, ASEBIO has managed the 'Plan de Internacionalización de ICEX para las empresas biotecnológicas', supporting Spanish biotech companies in international expansion. ICEX provides funding and programmatic support for international missions, trade events, and market access activities.
  • Ministerio de Industria y TurismocoreOthersThe Ministry published the PROFARMA 2025-2026 resolution where 15 ASEBIO members received Excellent to Acceptable classifications. ASEBIO advocates for the sector with this ministry and participates in the PERTE Salud de Vanguardia Alliance.
  • Ministerio de Ciencia e InnovacióncoreOthersThe Ministry leads national science and innovation policy. ASEBIO participates in the PERTE Salud de Vanguardia Alliance and collaborates on initiatives to convert excellent science into technology and innovation made in Spain.
  • SEBiot (Sociedad Española de Biotecnología)coreStrategic or Co-development PartnerASEBIO and SEBiot collaborate on the Joven Talento Biotech program to support young researchers and students. Entities must be ASEBIO members, Plataforma Biotech members, or associated with SEBiot to participate in the program.
  • Plataforma Biotech (PBio)coreStrategic or Co-development PartnerThe Plataforma Biotech (PBio) is managed by ASEBIO and is a digital ecosystem that connects biotech actors, publishes capabilities and products, facilitates bilateral meetings, and promotes collaboration. Funded by the Agencia Estatal de Investigación.
  • PERTE Salud de Vanguardia AllianceflagshipStrategic or Co-development PartnerASEBIO participates in the PERTE Salud de Vanguardia Alliance bringing together public administrations, regional governments, scientific societies, business associations, and patient groups. This strategic initiative represents a 1,469 million euro investment (2021-2023) expected to generate over 4,300 million euros in GDP and 12,700 new jobs.
  • Ministerio de SanidadcoreOthersASEBIO collaborates with the Ministry of Health on PERTE Salud de Vanguardia initiatives and healthcare innovation policy. Ministers Diana Morant and Carolina Darias led the alliance formation in April 2022.
  • FarmaindustriaminorStrategic or Co-development PartnerCollaboration within the XV Conferencia Anual de las Plataformas Tecnológicas de Investigación Biomédica, organized alongside Farmaindustria, Fenin, Nanomed Spain and other platforms with over 700 registered attendees.
  • Fenin (Federación Española de Empresas de Tecnología Sanitaria)minorStrategic or Co-development PartnerCo-organizer of the XV Conferencia Anual de las Plataformas Tecnológicas de Investigación Biomédica along with ASEBIO, Farmaindustria, and other sector platforms.
  • Plataforma de Mercados BiotecnológicoscoreStrategic or Co-development PartnerCollaboration on the 'Un día con una #MujerBiotech' program and other initiatives connecting female students with biotech professionals. This platform represents a network of biotech companies for partnering and market development.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

The Spanish Association of Biotech companies (ASEBIO) competitors and assessment

Company assessment

Broad incumbents

  • BIO (Biotechnology Innovation Organization): The largest US biotech industry association, representing 1,000+ members and organizing the BIO International Convention. ASEBIO is the Spanish national analogue at smaller scale, with comparable functions (policy advocacy, partnering events, member services) but concentrated in Spain rather than globally.
  • EuropaBio: The European biotechnology industry federation based in Brussels, representing national associations and corporate members across Europe. ASEBIO participates in EuropaBio consultations on EU policy (Biotech Act) and serves a comparable ecosystem-coordinator function at national level.

Direct peers

  • France Biotech: French biotech trade association representing healthtech and biotech startups/SMEs in France. ASEBIO and France Biotech share a near-identical role: national ecosystem advocacy, policy lobbying, partnering events and startup support in adjacent European biotech markets.
  • BIA (UK BioIndustry Association): The UK's national trade association for the life sciences and biotech industry. BIA performs the same core functions as ASEBIO (policy advocacy, networking, conferences, partnering) but for a larger and more mature UK ecosystem.
  • BIO Deutschland: Germany's biotechnology industry association, representing SMEs and large biotechs. Operates as the German counterpart to ASEBIO with analogous services (annual reports, partnering events, policy work) in a larger national market.
  • Swiss Biotech Association: National biotech industry association for Switzerland, organizing Swiss Biotech Day and representing Swiss biotech at EU/global level. Directly comparable to ASEBIO in scope and member-services model, but serving the more established Swiss ecosystem.
  • AusBiotech: Australia's national biotech industry association with similar functions: policy advocacy, internationalization support, member events and sector reports. Comparable to ASEBIO as a national trade body for a mid-sized biotech ecosystem.
  • BIOTECanada: Canada's national biotechnology industry association. Performs equivalent trade-association functions (BIO convention participation, policy advocacy, member services) for the Canadian biotech ecosystem.

Others

  • Farmaindustria: Spanish pharmaceutical industry association and ASEBIO's listed partner (XV Conferencia Anual de Plataformas Tecnológicas). Adjacent rather than competitive — Farmaindustria represents large pharma while ASEBIO represents biotech — but they co-organize platforms and share policy space in Spain.
  • Fenin: Spanish federation of healthcare technology companies (medical devices, diagnostics, digital health). Co-organizer with ASEBIO of the XV Conferencia Anual de Plataformas Tecnológicas; an adjacent health-innovation trade body with overlapping member ecosystems in Spain.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

The Spanish Association of Biotech companies (ASEBIO) social profiles

Digital presence

The Spanish Association of Biotech companies (ASEBIO) financial estimates

Financial estimate

Revenue estimate

Valuation estimate

The Spanish Association of Biotech companies (ASEBIO) leadership team

Management profile

Number of profiles

Profiles1 record

The Spanish Association of Biotech companies (ASEBIO) funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

The Spanish Association of Biotech companies (ASEBIO) M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The Spanish Association of Biotech companies (ASEBIO)

What does The Spanish Association of Biotech companies (ASEBIO) do?

ASEBIO is a Spanish non-profit trade association that represents and convenes the national biotechnology sector. It sells membership to biotech companies and delivers a portfolio of services: the annual Informe AseBio sector report, the Plataforma Biotech digital partnering platform, the BIOSPAIN conference and AseBio Investor Day events, a job board, an R&D funding observatory, and talent development programs. Its core activity is intermediating between Spanish biotech companies, research institutions, government bodies, and international markets.

Is The Spanish Association of Biotech companies (ASEBIO) a public or private company?

The Spanish Association of Biotech companies (ASEBIO) is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was The Spanish Association of Biotech companies (ASEBIO) founded?

The Spanish Association of Biotech companies (ASEBIO) was founded in 1999. It employs 11 to 50 people.

Where is The Spanish Association of Biotech companies (ASEBIO) based?

The Spanish Association of Biotech companies (ASEBIO) is headquartered in Madrid, Spain, in the Europe region.

Who are The Spanish Association of Biotech companies (ASEBIO)'s main competitors?

Broad incumbents on record are BIO (Biotechnology Innovation Organization) and EuropaBio. Direct peers are France Biotech, BIA (UK BioIndustry Association), BIO Deutschland, Swiss Biotech Association, AusBiotech and BIOTECanada. Others are Farmaindustria and Fenin.

Does The Spanish Association of Biotech companies (ASEBIO) have an API?

No public API is recorded for The Spanish Association of Biotech companies (ASEBIO).

What industry is The Spanish Association of Biotech companies (ASEBIO) in?

The Spanish Association of Biotech companies (ASEBIO)'s product category is Biotechnology Trade Association Services. Its primary akta.pro industry code is HLAAADAC, Antisense Oligonucleotides (ASO) Therapeutics (splice modulation/knockdown). Its NAICS code is 6115 and its SIC code is 8200.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Labiotech.euBIOSPAIN 2026: Spain’s flagship biotech event is going annualBIOSPAIN 2026 returns September 29 to October 1, 2026 in Bilbao, becoming an annual event after two decades. The conference, organized by AseBio, has grown to over 1,000 companies and 2,400 attendees, with the UK as guest nation and Latin American participation expected.GlobeNewswireORYZON to Provide Corporate Progress Updates at Several Events in MayOryzon Genomics will provide corporate progress updates at four international events in May, including Bio-Equity Europe, Asebio Investor Day, RSC Hot Topics, and Foro Medcap. The company has two LSD1 inhibitors, vafidemstat and iadademstat, in Phase II trials for CNS and oncology, with iadademstat dosed to over 130 cancer patients.PR NewswireBIOSPAIN 2018 privádza účastníkov do hlavnej krajiny biotechnológie v EurópeASEBIO and the regional government of Andalusia announced that Sevilla will host the ninth edition of the BIOSPAIN biotechnology fair from September 25 to 27, 2018. The event is positioned as a leading platform for international cooperation in the sector, featuring key investors such as Johnson & Johnson Innovation and Ysios Capital Partners alongside discussions on biomedicine and agriculture. Organizers are implementing new registration policies to attract researchers and academics while leveraging a dedicated mobile application to facilitate networking among attendees.PR NewswireBIOSPAIN 2018 invite les utilisateurs à la plaque tournante des biotechnologies en EuropeThe Spanish Bioenterprises Association (ASEBIO) and the Regional Government of Andalusia have announced that Seville will host the 9th biennial BIOSPAIN event from September 25-27, 2018 at the FIBES Congress and Exhibition Centre. The event aims to strengthen Spain's international position in biotechnology and has become the fifth largest biotech event globally in terms of business meetings, with the 2016 edition attracting 1,750 delegates from 800 companies across 29 countries. BIOSPAIN 2018 features a conference program focused on biomedicine, agri-food biotechnology, and industrial biotechnology, along with an investor forum with confirmed participants from seven countries.PR NewswireBIOSPAIN 2018 přivádí účastníky do hlavní země biotechnologií v EvropěThe Spanish Bioindustry Association (ASEBIO) and the regional government of Andalusia announced that Seville, Spain will host the ninth edition of the biennial BIOSPAIN biotechnology event from September 25–27, 2018 at the FIBES exhibition center, positioning it as a platform to strengthen Spain's international biotech standing. The 2016 edition drew 1,750 representatives from 800 companies across 29 countries, making it the fifth-largest global biotech conference by business meetings and the largest in a single European country. Confirmed investors for the 2018 edition include Ysios Capital Partners, Andera Capital, Biogeneration Ventures, Fund+, and Johnson & Johnson Innovation, with topics spanning Alzheimer's disease, immunotherapy, gene editing, and bioeconomy.PR NewswireInnovationsführer von Lateinamerikas Biopharma prägen vom 29. - 30. November das Programm des weltweiten Partnering-Events für Lifesciences, Biolatam® 2016The third edition of Biolatam, an international lifesciences partnering conference, took place November 29-30, 2016 in San Juan, Puerto Rico, bringing together over 300 lifesciences dealmakers from pharma, biotechnology, and service companies across the USA, Latin America, and Europe. The conference focused on business development, alliance management, and financing opportunities in Latin America's biotech sector, featuring innovations in health, agro-food, industrials, and emerging medtech/digital technology. The event was organized by EBD Group and ASEBIO in collaboration with Puerto Rico Science, Technology & Research Trust, with speakers representing companies and research institutions from Puerto Rico, Costa Rica, Spain, and the USA.PR NewswireLes leaders de l'innovation biopharmaceutique en Amérique latine en tête du programme lors de l'événement mondial de partenariat dans les sciences de la vie, Biolatam® 2016, qui se tiendra les 29 et 3The third edition of the Biolatam® international life sciences partnering conference will be held in San Juan, Puerto Rico on November 29-30, 2016, organized by EBD Group and ASEBIO in collaboration with Puerto Rico Science, Technology & Research Trust. The event will bring together over 300 negotiators from pharmaceutical, biotech, and service companies representing entities from the United States, Latin America, and Europe. Key industry speakers include representatives from PharmaMar, Catalent Biologics, Cognitiva IBM Watson Strategic Partner, and CRBioMed, among others.